PharmiWeb.com - Global Pharma News & Resources

Medical comms - Press Releases

Date Title Company
08-Jun-2020 Novo Holdings REPAIR Impact Fund Launches Global Call for New Investment Proposals to Fight AMR Novo Holdings
08-Jun-2020 Vectura signs agreement with Aerami Therapeutics Inc Vectura Group plc
08-Jun-2020 Helsinn announces FDA acceptance of IND application for TAS0953/HM06 in Patients with Advanced Solid Tumors with RET Gene Abnormalities Helsinn Group
05-Jun-2020 Calliditas Therapeutics prices its initial public offering on The Nasdaq Global Select Market in the United States Calliditas Therapeutics AB
05-Jun-2020 AstraZeneca presents new data across continuum of care from its broad renal portfolio at ERA-EDTA 2020 Virtual Congress AstraZeneca
05-Jun-2020 UCB Shares Breadth of Innovative New Data from Rheumatology Portfolio for EULAR 2020 E-Congress UCB
05-Jun-2020 Herbert Smith Freehills advises Acacia on its acquisition of shares in up to 19 public and private life sciences companies Herbert Smith Freehills’
05-Jun-2020 Sosei Heptares notes Phase IIIb ARGON study with Enerzair® Breezhaler® (QVM149) meets primary endpoint in patients with uncontrolled asthma Sosei Group Corporation
04-Jun-2020 Lupin signs distribution agreements in key EU territories for orphan drug NaMuscla® Lupin
04-Jun-2020 Hyloris Pharmaceuticals Announces Intention to Launch an Initial Public Offering on Euronext Brussels Hyloris Pharmaceuticals SA
04-Jun-2020 AMRYT AND SWIXX SIGN DISTRIBUTION DEAL FOR MYALEPTA ACROSS 17 JURISDICTIONS IN CENTRAL AND EASTERN EUROPE (“CEE”) AMRYT PHARMA PLC
04-Jun-2020 MARINOMED EXPANDS INTO ITALY AND BROADENS ITS PORTFOLIO Marinomed Biotech AG
04-Jun-2020 Santhera Receives Financing Commitment of up to CHF 20 Million from Fund Managed by Highbridge Capital Management Santhera Pharmaceuticals
04-Jun-2020 Chi-Med Announces the Continuation of Phase III FRUTIGA Study of Fruquintinib in Second-Line Gastric Cancer in China Following a Planned Interim Data Review Chi-Med
04-Jun-2020 Singapore's LABMED shipped over 20 million masks to meet global demand LABMED
04-Jun-2020 Smarter and faster FEP calculations enable more cost-efficient drug research Cresset
04-Jun-2020 Almac Group Welcomes Confirmation that Northern Ireland’s Pharmaceutical Industry will Maintain Regulatory Alignment with the EU Post-Brexit Almac Group
04-Jun-2020 Celltrion Healthcare showcases positive 1-year data and budget impact analysis for novel subcutaneous formulation of infliximab in patients with rheumatoid arthritis at the European E-Congress of Rheumatology 2020 Celltrion
04-Jun-2020 AlzeCure announces positive data from clinical study with ACD856 About AlzeCure® Pharma
04-Jun-2020 UNLOCKING THE POWER OF THE IMMUNE SYSTEM: UNCOVERING THE IMMUNOGENIC EFFECT OF CHEMOTHERAPY Cancer Research UK